Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients

References

• Chronic Obstructive Pulmonary Disease, 2009. Statistics Canada. Available at: http://www.statcan.gc.ca/pub/82-625-x/2010002/article/11273-eng.htm. [Last accessed 5 May 2011]
   Google Scholar
• Chronic Obstructive Pulmonary Disease (COPD). Public Health Agency of Canada. 2008. Available at: www.phac.aspc.gc.ca/cd-mc/crd-mrc/copd-mpoc-eng.php [Last accessed 18 February 2011]
   Google Scholar
• COPD Facts and Figures. From Life and Breath: Respiratory Disease in Canada. Report. Public Health Agency of Canada. 2007
   Google Scholar
• Health Indicators 2008. Canadian Institute of Health Information. 2008. Available at: https://secure.cihi.ca/free_products/HealthIndicators2008_ENGweb.pdf [Last accessed 3 April 2014]
   Google Scholar
• Table 105-0501 - Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2012 boundaries) and peer groups, occasional, CANSIM. Statistics Canada. 6-17-2013. http://www5.statcan.gc.ca/cansim/a05?lang=eng&id=1050501 [Last accessed 17 October 2013]
   Google Scholar
• Sharafkhaneh A, Petersen NJ, Yu HJ, et al. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affair population. Int J Chron Obstruct Pulmon Dis 2010;5:125–32
   PubMedGoogle Scholar
• Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis 2010;5:341–9
   PubMedGoogle Scholar
• Mittmann N, Kuramoto L, Seung SJ, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 2008;102:413–21
   PubMed Web of Science ®Google Scholar
• Deaths: preliminary data for 2011. Hoyert DL and Xu JQ. Hyattsville, MD: National Center for Health Statistics, 2012. Natl Vital Stat Rep
   Google Scholar
• O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;15 Suppl A:1A–8A
   PubMed Web of Science ®Google Scholar
• Global Strategy for Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=989 [Last accessed 16 February 2011]
   Google Scholar
• Pocket guide to COPD diagnosis, management, and prevention. A guide for Health Care Professionals. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2013. Available at: http://www.goldcopd.org/uploads/users/files/GOLD_Pocket_2013_Mar27.pdf. [Last accessed 17 October 2013]
   Google Scholar
• O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 2007;14:5B–32B
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2014. http://www.goldcopd.org/uploads/users/files/GOLD_Report2014_Feb07.pdf [Last accessed 3 April 2014]
   Google Scholar
• Agh T, Inotai A, Meszaros A. Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2011;82:328–34
   PubMed Web of Science ®Google Scholar
• Arnold E, Bruton A, Ellis-Hill C. Adherence to pulmonary rehabilitation: A qualitative study. Respir Med 2006;100:1716–23
   PubMed Web of Science ®Google Scholar
• Barnestein-Fonseca P, Leiva-Fernandez J, Vidal-Espana F, et al. Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study. Trials 2011;12:40
   PubMed Web of Science ®Google Scholar
• Bender BG. Nonadherence to COPD Treatment: What Have We Learned and What Do We Do Next? COPD 2012;9:209–10
   PubMedGoogle Scholar
• Bischoff EWMA, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax 2011;66:26–31
   PubMed Web of Science ®Google Scholar
• Blais L, Forget A, Ramachandran S. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Clin Ther 2010;32:1320–8
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008;63:831–8
   PubMed Web of Science ®Google Scholar
• Butler RJ, Davis TK, Johnson WG, Gardner HH. Effects of nonadherence with prescription drugs among older adults. Am J Manag Care 2011;17:153–60
   PubMed Web of Science ®Google Scholar
• Carls GS, Roebuck MC, Brennan TA, et al. Impact of medication adherence on absenteeism and short-term disability for five chronic diseases. J Occup Environ Med 2012;54:792–805
   PubMed Web of Science ®Google Scholar
• Castaldi PJ, Rogers WH, Safran DG, Wilson IB. Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease. CHEST Journal 2010;138:614–20
   PubMed Web of Science ®Google Scholar
• Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD 2012;9:251–8
   PubMedGoogle Scholar
• Charles MS, Blanchette CM, Silver H, et al. Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin 2010;26:2421–9
   PubMed Web of Science ®Google Scholar
• Chen AM, Bollmeier SG, Finnegan PM. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease. Ann Pharmacother 2008;42:1832–42
   PubMed Web of Science ®Google Scholar
• George J, Kong DC, Stewart K. Adherence to disease management programs in patients with COPD. Int J Chron Obstruct Pulmon Dis 2007;2:253–62
   PubMedGoogle Scholar
• George J, Kong DCM, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with copd*. CHEST Journal 2005;128:3198–204
   PubMed Web of Science ®Google Scholar
• Halpern R, Baker CL, Su J, et al. Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease. Patient Prefer Adherence 2011;5:375–88
   PubMed Web of Science ®Google Scholar
• Han MK. Medication adherence in COPD: what have we learned? Thorax 2009;64:922–3
   PubMed Web of Science ®Google Scholar
• Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 2008;30:509–14
   PubMed Web of Science ®Google Scholar
• Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med 2012;27:1506–12
   PubMed Web of Science ®Google Scholar
• Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly 2012;142:w13567
   PubMed Web of Science ®Google Scholar
• Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007;32:603–11
   PubMed Web of Science ®Google Scholar
• Laforest L, Denis F, Van GE, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J 2010;19:148–54
   PubMedGoogle Scholar
• Mapel DW, Hurley JS, Dalal AA, Blanchette CM. The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management. Prim Care Respir J 2010;19:93–103
   PubMedGoogle Scholar
• Neugaard BI, Priest JL, Burch SP, et al. Quality of care for veterans with chronic diseases: performance on quality indicators, medication use and adherence, and health care utilization. Popul Health Manag 2011;14:99–106
   PubMed Web of Science ®Google Scholar
• Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008;3:371–84
   PubMedGoogle Scholar
• Schmier JK, Halpern MT, Jones ML. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence. Drugs Aging 2005;22:717–29
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L, Wei YJ, Qian J, et al. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Am J Geriatr Pharmacother 2012;10:201–10
   PubMed Web of Science ®Google Scholar
• Sugawara T, Nanjo Y, Yamazaki M, et al. Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder. J Am Geriatr Soc 2009;57:919–20
   PubMed Web of Science ®Google Scholar
• Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med 2007;101:1895–902
   PubMed Web of Science ®Google Scholar
• Tan JY, Chen JX, Liu XL, et al. A meta-analysis on the impact of disease-specific education programs on health outcomes for patients with chronic obstructive pulmonary disease. Geriatr Nurs 2012;33:280–96
   PubMed Web of Science ®Google Scholar
• Toy EL, Beaulieu NU, McHale JM, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med 2011;105:435–41
   PubMed Web of Science ®Google Scholar
• Tsagaraki V, Markantonis SL, Amfilochiou A. Pharmacotherapeutic management of COPD patients in Greece--adherence to international guidelines. J Clin Pharm Ther 2006;31:369–74
   PubMed Web of Science ®Google Scholar
• van Boven JF, Chavannes NH, van der MT, et al. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med 2014;108:103–13
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64:939–43
   PubMed Web of Science ®Google Scholar
• Yu AP, Guérin A, Ponce de Leon D, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. Journal of Medical Economics 2011;14:486–96
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83
   PubMedGoogle Scholar
• D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996;49:1429–33
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–9
   PubMed Web of Science ®Google Scholar
• Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144–53
   PubMed Web of Science ®Google Scholar
• Suissa S. The case-time-control design. Epidemiology 1995;6:248–53
   PubMed Web of Science ®Google Scholar
• Enright PL. COPD patients with higher education are much less likely to adhere to prescribed daily inhaler use. Respir Med 2010;104:760–1
   PubMed Web of Science ®Google Scholar
• Khdour MR, Hawwa AF, Kidney JC, et al. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol 2012;68:1365–73
   PubMed Web of Science ®Google Scholar
• Krigsman K, Nilsson JL, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidem Drug Safe 2007;16:441–8
   PubMed Web of Science ®Google Scholar
• Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 2013;107:1481–90
   PubMed Web of Science ®Google Scholar